Brokerages Set Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Target Price at $12.00
Shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) have been given a consensus rating of “Hold” by the six analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts...









